Discovery Labs Continues Dialogue With FDA On Surfaxin Surfactant
This article was originally published in The Pink Sheet Daily
The company now forecasts a second quarter 2006 launch of the synthetic surfactant.
You may also be interested in...
The company does not foresee the need for additional clinical trials.
Firm notes strong uptake of the product in 2006, as well as more than $400 million in Thalomid sales for the year during earnings call.